share_log

NeuroSense Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(25.77%)

NeuroSense Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Alon Ben-Noon(25.77%)

2023/04/05 08:02
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息